Arkstone Support

OneChoice® is a patent-pending technology that selects the most appropriate treatment regimen for a particular patient given the organisms present, resistan...

The OneChoice Report and OneChoice Plus are intended to be used in conjunction. The OneChoice Report is the provider's inital source of information ...

The OneChoice Report is classified as a clinical decision-making tool under FDA guidelines. This means that while our recommendations can help providers mak...

OneChoice recommendations are based on published and accepted medical data. This includes Infectious Disease Society of America (IDSA) and the CDC guideline...

No. Arkstone only analyzes data sent by the lab which includes organisms and resistance genes detected, patient demographics, diagnosis codes, and patient a...

No.  By the very nature of microbial life, in any given lab test there are going to be any number of organisms or genes that are not tested for. Basing ...

OneChoice® provides dosing for antibiotics based on some patient-specific criteria giving prescribers a baseline point of reference. However, dosing may not...

Arkstone provides the minimal duration of treatment required to treat simple infections, however, prescribers should adjust accordingly based on the clinica...

Arkstone does not make any diagnosis determinations. Treatment recommendations base the diagnosis on the ICD10 code the provider enters on the laborator...

Arkstone will still provide a OneChoice Report, however, the recommendation will only take into account the information that was sent by the lab. Infor...